Drug profile · INN
ingenol mebutate
PICATO
ingenol mebutate (PICATO) is a unknown. Route of administration: topical. Current US regulatory status: approved.
FDA: approved EMA: withdrawn Dermatologicals (D06) D06BX02
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — ingenol mebutate
- US status
- approved
- Class
- Dermatologicals (D06)
- Route
- TOPICAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
ingenol mebutate (PICATO) is a unknown. Route of administration: topical. Current US regulatory status: approved.
Key facts
INN ingenol mebutate
Brand PICATO
Mechanism Unknown
Therapeutic class Dermatologicals (D06)
Route TOPICAL
Formulation GEL
ATC code D06BX02
Mechanism of action
Unknown
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | withdrawn | — |
Related & competitor drugs
Frequently asked questions
What is ingenol mebutate?
ingenol mebutate (PICATO) is a unknown. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for ingenol mebutate?
PICATO is a marketed brand name for ingenol mebutate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ingenol mebutate?
ingenol mebutate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.